Literature DB >> 23039989

Metabolic control and treatment patterns in patients with type 1 diabetes in Castilla-La Mancha: the DIAbetes tipo 1 in Castilla La Mancha study.

Julia Sastre1, Pedro José Pinés, Jesús Moreno, Miguel Aguirre, Benito Blanco, Dulce Calderón, Sandra Herranz, Carlos Roa, José Lopez.   

Abstract

OBJECTIVE: To assess glycemic control, the degree of control of cardiovascular risk factors, and treatment schemes used in patients with type 1 diabetes mellitus (T1DM) in Castilla-La Mancha (Spain). PATIENTS AND METHODS: A cross-sectional, multicenter study on adult patients with T1DM seen at outpatient endocrinology clinics for 12 months (from September 2009 to August 2010). Diabetes duration was > 5 years in all cases. Sociodemographic, clinical, anthropometric, and laboratory variables were collected, as well as treatment data. A multivariate logistic regression analysis was used to assess variables independently associated to good glycemic control.
RESULTS: A total of 1465 patients (48.5% women) with a mean age of 39.4±13.5 years and a mean diabetes duration of 19.4±10.6 years, were enrolled. Mean glycosylated hemoglobin (HbA1c) level was 7.8%, and 26% had HbA1c values ≤7%. Predictors of good glycemic control (HBA1c ≤7%) included intensive insulin treatment [odds ratio (OR): 2.56], non-smoking status (OR: 1.66), and a higher educational level (OR: 1.33). Fifteen percent of patients were obese, 35% had dyslipidemia, 23% were hypertensive, and 26% smoked. Four or more of the recommended control goals were achieved by 68% of patients, but more than 33% required additional drug treatment.
CONCLUSIONS: Glycemic control was inadequate in this cohort of T1DM patients. Promotion of healthy attitudes and intensification of insulin treatment may improve glycemic control. Prevalence of cardiovascular risk factors is high, although a great proportion of patients achieve good lipid and blood pressure control.
Copyright © 2012 SEEN. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23039989     DOI: 10.1016/j.endonu.2012.07.003

Source DB:  PubMed          Journal:  Endocrinol Nutr        ISSN: 1575-0922


  6 in total

Review 1.  Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population.

Authors:  Siang Ing Lee; Mitesh Patel; Christopher M Jones; Parth Narendran
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

Review 2.  Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review.

Authors:  Anne Scott; Duncan Chambers; Elizabeth Goyder; Alicia O'Cathain
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

3.  Psychometric properties of a questionnaire to measure adherence to treatment in patients with type 1 diabetes mellitus.

Authors:  Carmen Grau-Del Valle; José Francisco Marco-Expósito; Eva Solá; Inmaculada Montoya-Castilla; Carlos Morillas; Antonio Hernández-Mijares; Celia Bañuls
Journal:  Nurs Open       Date:  2022-04-20

4.  Factors Affecting Glycemic Control among Saudi Children with Type 1 Diabetes Mellitus in Aseer Region, Southwestern Saudi Arabia.

Authors:  Saleh M Al-Qahtani; Ayed A Shati; Youssef A Alqahtani; Ali A AlAsmari; Mohammed A Almahdi; Amjad A Al Hassan; Ali M Alhassany; Rana A Shathan; Rawa M Aldosari; Abdullah S AlQahtani; Shamsun Nahar Khalil
Journal:  Int J Environ Res Public Health       Date:  2022-09-14       Impact factor: 4.614

5.  Factors associated with high levels of glycated haemoglobin in patients with type 1 diabetes: a multicentre study in Brazil.

Authors:  Carine Sousa Andrade; Guilherme Sousa Ribeiro; Carlos Antonio Souza Teles Santos; Raimundo Celestino Silva Neves; Edson Duarte Moreira
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692

6.  Heart rate dynamics during cardio-pulmonary exercise testing are associated with glycemic control in individuals with type 1 diabetes.

Authors:  Othmar Moser; Max L Eckstein; Olivia McCarthy; Rachel Deere; Stephen C Bain; Hanne L Haahr; Eric Zijlstra; Tim Heise; Richard M Bracken
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.